----- Original Message -----
From: "Teresa Polk" <udcrsvp(a)swfmesa.com>
To: <pbfotil(a)1stchoiceleddisplays.com>
Sent: Saturday, February 11, 2006 5:18 PM
Subject: Re: Feb 13, 2006 Stock Opportunities on Wall Street
On Monday February 13...
WATCH ***RLYC*** LIKE A HAWK!!!
FRIDAY CLOSE PRICE: 0.025 (+25.00% From the previous trading day)
PlNKSHEETS SYMBOL: RLYC
COMPANY NAME: Relay Capital Corp.
Relay Capital Corp. Announces Restructuring of Payroll Processing
Marketing Program
Friday January 27, 9:15 am ET
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Jan. 27, 2006--Relay Capital Corp.
(Pink Sheets: RLYC - News; www . relaycorp . com), a provider of
stored-value cards and other financial services, today announced
that it will mushroom its payroll processing marketing program by
joint ventures that allow both distributors & marketing companies
to offer the payroll processing product via their own marketing
channels. Relay expects revenues generated in their payroll
processing sector to increase by as much as 10% to 15% in their
first quarter as a result of this restructuring.
"There are literally thousands of companies in the U.S. looking
for more efficient ways to process and manage their payroll.
Many of these companies are working toward simpler solutions for
their business than what is currently in the marketplace today.
By restructuring our marketing program, we potentially reach
thousands of companies looking to revamp their payroll processing
in much less time," stated E. Reese Bogle, Relay Capital CEO.
"The key to us is marketing distribution. Our payroll processing
sells itself once the marketing message has been delivered,"
Bogle concluded.
In December of 2005, Relay Capital offered web seminars of their
payroll card services, making an introduction to the program easy
for many companies. Interested companies have been able to enroll
for the seminar at www . relaycorp . com. "Our program helps companies
find and implement a better way to administer payroll and benefits
for their employees, while saving on many of the costs connected
to the processing of payroll," Mr. Bogle explained.
About Relay Capital Corporation:
Relay Capital Corporation is a developer and marketer of a wide
range of prepaid financial services, which has rapidly grown
into a multi-billion dollar industry with no slow-down in
continued growth. Relay's services include pre-paid stored value
cards, reward cards, employee payroll cards, gift, retail and
affinity group cards, travel cards and fund transfer cards.
Relay Capital Corporation encompasses both the marketing and
distribution of pre-paid and pay-transfer cards in concert with
the development of loading centers. Loading centers are retail
locations, such as convenience stores, check cashing facilities
or other types of retail facilities serving to dispense or
receive cash facilitating transactions for the stored-value
card consumer.
REMOVE DIRECTIONS: Send blank email to
info(at)tentwelvecorp(dot)com or call (310)5987434
DISCLAIMER: Information within this email contains "forward looking
statements" within the meaning of Section 27a of the Securities act
of 1933 and Section 21B of the Securities exchange act of 1934.
Any statements that express or involve discussions with respect
to predictions, expectations, beliefs, plans, projections, objectives,
goals, assumptions or future events or performance are not statements
of historical fact and may be "forward looking statements."Forward
looking statements are based on expectations, estimates and
projections at the time the statements are made that involve a
number of risks and uncertainties which could cause actual results
or events to differ materially from those presently anticipated.
The publisher of this newsletter does not represent that the
information contained in this message states all material facts or
does not omit a material fact necessary to make the statements
therein not misleading. All information provided within this email
pertaining to investing, stocks, securities must be understood as
information provided and not investment advice. The publisher of this
newsletter advises all readers and subscribers to seek advice from
a registered professional securities representative before deciding
to trade in stocks featured within this email. None of the material
within this report shall be construed as any kind of investment
advice or solicitation. Many of these companies are on the verge
of bankruptcy. You can lose all your money by investing in this stock.
The publisher of this newsletter is not a re gistered invest ment advisor.
Subscribers should not view information herein as legal, tax,
accounting or investment advice. Any reference to past performance(s)
of companies is specially selected to be referenced based on the
favorable performance of these companies. You would need perfect
timing to achieve the results in the examples given. There can be
no assurance of that happening. Remember, as always, past performance
is n e v e r indicative of future results and a thorough due diligence
effort, including a review of a company's filings when available,
should be completed prior to investing. In compliance with
the Securities act of nineteen hundred thirty three, Section 17(b),
the publisher of this newsletter discloses they received payment from
an unaffiliated third party for the circulation of this report.
Be aware of an inherent conflict of interest resulting from such
compensation due to the fact that this is a paid advertisement and
is not without bias. All factual information in this report was
gathered from public sources, including but not limited to Company
Websites and Company Press Releases. The publisher of this newsletter
believes this information to be reliable but can make no guarantee
as to its accuracy or completeness. Use of the material within this
email constitutes your acceptance of these terms.
T O P D O G S
_____________________________________________________________
Dermisonics Develops Working Model of Antiseptic Wand In The
$1.2 Billion Wound Care Market
Now In Talks With U.S. Army to Build Battlefield Version
_____________________________________________________________
P rofiled: Dermisonics Inc.
Sec t0r: Conglomerates
Symb 0l: DMSI
{lt2} $0.47
We have reviewed this new stock in our listings and we are more than excited. This company
has developed a new antiseptic delvery system that not only makes the application of
antiseptic to wounds, its ability to penitrate deeper than surface cover can actually
help prevent against needed amputations due to uncontrolled infections.
It is no wonder the US Military is interested in bulding a battlefield version to help
protect our soldiers by better equiping the field medics.
Just check out their website and reveiw the full news release below. With an annoucement
like this in the market we are very excited to see where this stock goes tomorrow.
The H eadlines:
WEST CONSHOHOCKEN, Pa., Feb. 6 /CNW/ -- Dermisonics, Inc. (OTC Bulletin Board: DMSI.OB),
a pioneer in the development of ultrasonic transdermal drug-delivery technologies,
announced today that it has completed the first working model of its A-Wand antiseptic
delivery system and is in talks with the Army Institute of Surgical Research under the
Combat Casualty Care Research Program to develop a battlefield version.
The A-Wand (TM) is a handheld, portable, ultrasonic wand device for applying antiseptic
solutions to cuts, abrasions and wounds with a replaceable Patch-Cap (TM), which holds
up to 40 ml of antiseptic solution. It uses alternating ultrasonic waveforms to enlarge
the diameter of the skin pores enabling antiseptics to permeate through the skin
(Stratum Corneum) into the dermis through the sweat pores.
Attacks Critical Problem of Infections in Wounded Soldiers -- Infection is a major,
potentially lethal, battlefield hazard for wounded soldiers before they can receive
full medical treatment in a hospital. The Medic on the scene applies antiseptic and
bandages the wound but the antiseptic only affects the outermost layers of the damaged
tissue. Infection frequently results and is a major cause of amputations.
The A-Wand Encapsulates the Wounded Area with Antiseptic -- The A-Wand would be used by
Medics in the field, by Mash units and for follow-up wound care to significantly reduce
this hazard. Through the use of the A-Wand's ultrasound system, the antiseptic solution
is "pushed" to the deeper tissue where it can more effectively fight infection by
surrounding and encapsulating the wounded area with antiseptic. It also has the added
advantage of being able to penetrate scared tissue without damaging this basic body
defense system.
Technology inventor and Dermisonics Executive Vice-President Bruce Redding commented,
"The A-Wand represents a huge opportunity for Dermisonics and the various patients who
could benefit from increased infection-resistant technologies. Dermisonics especially
is pleased by the response from the US Army and we hope this technology finds acceptance
in the field as soon as possible"
The Next Generation in the $1.2 Billion Wound Care Market -- The Company believes the
A-Wand will represent a significant shift in wound-care medical science and will
fundamentally change the $1.2 billion wound-care market.
Industry Opportunity and Receptivity -- As a harbinger of its immediate industry impact,
the Company has already received, in addition to the military, strong indications of
interest from major companies in the pharmaceutical and hospital fields.
{ov1}
Dermisonics is an intellectual property company and advanced technology
incubator that is primarily focused on the ongoing development, testing and
eventual commercialization of a transdermal patch that has been designed to
facilitate the efficient and needle-free delivery of drugs with large
molecular structures into the bloodstream. Its breakthrough system, called
the U-Strip, is based on a radical integration of microelectronics and
ultrasonic science with a product-carrying patch, and represents a quantum
leap in non- invasive, transdermal delivery technology. Tests have shown
that this system facilitates the transdermal delivery of insulin as well as
potentially at least 175 other existing drugs that at present cannot be
effectively delivered through the pores of the skin using conventionally
available transdermal technology due to their large molecular size. The
Company has also developed other portable ultrasonic systems for
applications in the medical (Antiseptic Wand) and skin care (U-Wand) fields.
G ood Trading
______________
Information within this em ail contains 4rward l0 0king statements within
the meaning of Section 27A of the Secu rities Act of nineteen thirty three
and Section 21B of the Securi ties Exch ange Act of nineteen thirty four. Any
statements that express or involve discussions with respect to predi ctions,
expec tations, beli efs, pla ns, projec tions, objec tives, goa ls, ass
umptions or future events or performance are not statements of historical
fact and may be 4rward 1o0king statements. Don't rely on them to make a
decision. As with many micr ocap st0c ks, today's com pany has disclosable material
items you need to consider in order to make an informed and intelligent
in_vest ment decision. These items include: a reliance on loans from
offi cers, some related party transactions, a goin concern opinion from its
auditor, no reven ues in its most recent quar ter, a large accumulated deficit,
default on not es pay able that could cause the com pany to lose its intellectual
property, and potential litigation over its technology. It is not an operating comp any
and is going to need fin ancing. Read the Company's S E C Fili ngs now, right now, before
you inve st. None of the material within this report shall be construed as any kind of in
vestment advi ce or solicitat ion. Many of these small compa nies are on the verge of
bankr uptcy. You can lose all your m0ny by in-ves ting in this st0c k. In
compliance with the Securi ties Act of 19 33, Sec tion 17(b),we disclose the receipt of
four hundred twenty five thousand free trading shares received from a third party, not
an officer, director or affiliate shareholder for our services. We intend to sell our
stock now. This could cause the stock to go down, resulting in losses for you. All
factual informa tion in this report was gathered from public sources, including but
not limited to Comp any Pre ss Releas es and Fili ngs.
